MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Diabetes: Asante Solutions sets IPO terms

Diabetes: Asante Solutions sets IPO terms

By

Diabetes: Asante Solutions sets IPO terms

Asante Solutions today set the terms for its initial public offering, saying it plans to offer 3.5 million shares at $13 to $15 apiece.

At the midpoint of the range, the flotation would fetch $49 million. Asante makes a modular insulin pump called the Snap that’s designed to use pre-loaded insulin cartridges.

The Sunnyvale, Calif.-based company, which 1st filed a confidential registration with the SEC last October, said in December that it plans to list on the NASDAQ exchange under the PUMP symbol. The offering is expected to price the week of Feb. 2, according to a regulatory filing.

Asante Solutions claims the Snap device as the 1st to feature pre-filled insulin cartridges and pump bodies designed for disposal after a week. The company said the modular design "enables a novel, consumer-oriented business model with free trials, $99 upgrades and lower upfront costs.”

The Snap system is available for a free, 28-day trial period, according to the filing. Upgrades to its remote controller, designed to be used for 4 years, go for $99 per update. Asante said the up-front cost of its device is $1,000, compared to the $4,000 to $6,000 cost of traditional pumps.

The Snap system won 510(k) clearance from the FDA in January 2013 for patients over age 21, for use with Eli Lilly‘s (NYSE:LLY) Humalog insulin cartridges. Asante said the Humalog cartridges own a roughly 50% share of the pre-filled insulin cartridge market.

"We initiated a limited launch in the 2nd quarter of 2013 and intend to use the proceeds of this offering to accelerate commercialization of the Snap system in the United States," the company said in the filing.

In case you missed it

RSS From Medical Design & Outsourcing

  • Integrated Polymer Solutions acquires IRP Group
    Integrated Polymer Solutions (“IPS”), a portfolio company of Arcline Investment Management, announced this week that it has acquired IRP Group. IRP designs and manufacturers elastomeric sealing components from its facilities in Southern California. Founded in 1999, the company is focused on the Class I and II medical device market as well as the aerospace &… […]
  • Interpower debuts plugs in new colors
    Interpower announced that its NEMA 5-20 hospital-grade plugs for use in North America now come in molded colors of clear, black or gray on 10-foot lengths of flexible cord. These molded plugs complement the company’s NEMA 5-20 hand-wired hospital-grade plugs. The North American 18A hospital-grade power cord on 14 AWG SJT cable and North American… […]
  • Portescap motors gain certification
    Portescap announced that its slotless brushless DC motors for respirators have received ISO 13485:2016 certification. Expanding on ISO 9001, this standard contains specific requirements for parts traceability and risk management activities throughout the design and development stages. It also requires process and software validations at defined intervals. Independent risk management and quality compliance firm DNV… […]
  • Instron launches update to product testing system
    Materials testing equipment and software developer Instron announced the launch of the Torsion Add-On 3.0 for universal testing systems. Recently redesigned to take advantage of the latest functionality offered by the new Instron 6800 series, this system offers a simpler, safer, and more intuitive user experience, according to Norwood, Mass.-based Instron. Instron introduced the Torsion… […]
  • Abiomed CEO Michael Minogue appointed as AdvaMed chairperson
    Medtech trade group AdvaMed today said it has appointed Abiomed (NSDQ:ABMD) president and CEO Michael Minogue as chairperson of the AdvaMed board of directors, effective immediately. Minogue will serve as chairperson of the trade association’s board of directors for two years. He has been a member of the board since 2007 and a member of the board… […]
  • Credit card-sized pump could enable ‘power clothing’ to help patients with mobility
    Robotic clothing that is entirely soft and could help people to move more easily is a step closer to reality thanks to the development of a new flexible and lightweight power system for soft robotics. The discovery by a team at the University of Bristol (UK) could pave the way for wearable assist devices for… […]
  • ACSYS Lasertechnik debuts quick-change laser system
    ACSYS Lasertechnik (Lenexa, Kan.) recently announced the development of its patent-pending, ultra-short pulse,  quick-change laser system for marking, engraving and cutting for medical device applications. The system uses a galvanometer scanner equipped with either f-theta marking optics or a laser cutting head to provide interchangeable flexibility and precision. When in marking mode, the system can… […]
  • 12 surgical robotics companies you need to know
    Surgical robotics remains a hot area in medtech — even as it faces headwinds from the COVID-19 pandemic. Intuitive Surgical (NSDQ:ISRG) pioneered robotic surgery through the early 2000s and remains the dominant player, but major companies including Medtronic (NYSE:MDT) and Johnson & Johnson (NYSE:JNJ) have big plans to enter the space and compete. Meanwhile, Stryker (NYSE:SYK) has built a… […]
  • Boston Scientific has another serious recall on the same heart device
    The FDA has declared a second Class I recall within a month on a Boston Scientific implantable cardioverter defibrillator (ICD). This recall, which the company initiated with a trio of warnings in December, notified physicians that 3,350 Emblem S-ICD model A209 and A219 devices may exhibit electrical overstress while delivering high-voltage therapy. Variations in header… […]
  • Fifth round of medtech user fee talks set to begin soon
    Every five years, the FDA, the medtech industry and the public sit down and hammer out how the agency should spend the money it collects in fees from medical device developers seeking approvals and clearances. The agency also uses the Medical Device User Fee Amendment (MDUFA) to set fees for biologics license applications, 513(g) requests for information and de… […]
  • The worst catheter-based device recalls of 2020
    The U.S. saw nine serious medical device recalls related to catheters in 2020 — up from four the previous year, according to the FDA. FDA in 2020 reported a total 33 medical device recalls at its most serious Class I level, down from 49 in 2019. The list of the most serious catheter-based device recalls… […]